← Leaderboards
German Rosas-Acosta
University Of Texas El Paso
$1,415,168
Attributed
$1,415,168
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $314.1K · FY2008–14$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,415,168 · 2
By mechanism
SC1$1,083,278 · 1
SC2$331,890 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas El Paso
Same institution · by research overlap
- Ming-Ying Leung$541,098
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectVirusVirus DiseasesVirus ReplicationVaccine ProductionViral ProteinsProteomicsInfluenzaLeadProteinsTransfectionUbiquitinAnti-InfluenzaViralAmericanInfectionCellsCellular TargetingInnovationKillingsPlayPropertyPost-Translational Protein ProcessingDrug Delivery Systems
Grant awards (7)
Molecular effects of SUMOylation on influenza virus infection: SUMO and NS1$261,625
SC1 · FY2014 · AI · contact PI
Molecular effects of SUMOylation on influenza virus infection: SUMO and NS1$245,928
SC1 · FY2013 · AI · contact PI
Molecular effects of SUMOylation on influenza virus infection: SUMO and NS1$261,625
SC1 · FY2012 · AI · contact PI
Molecular effects of SUMOylation on influenza virus infection: SUMO and NS1$314,100
SC1 · FY2011 · AI · contact PI
The Sumoylation System as a Novel Target for Anti-Influenza Therapies$109,890
SC2 · FY2010 · AI · contact PI
The Sumoylation System as a Novel Target for Anti-Influenza Therapies$111,000
SC2 · FY2009 · AI · contact PI
The Sumoylation System as a Novel Target for Anti-Influenza Therapies$111,000
SC2 · FY2008 · AI · contact PI